| Q43436739 | A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke |
| Q88454358 | A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation |
| Q44075213 | Acute direct current cardioversion: how 'dangerous' is it? |
| Q58969253 | Air Pollution Exposure – A Trigger for Myocardial Infarction? |
| Q33858941 | Air pollution exposure--a trigger for myocardial infarction? |
| Q34187660 | Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. |
| Q46248818 | Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative |
| Q43415636 | Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial |
| Q64102790 | Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care |
| Q36001150 | Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study |
| Q83169945 | Association of candesartan vs losartan with all-cause mortality in patients with heart failure |
| Q44620783 | Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study |
| Q36274149 | Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea. |
| Q47719372 | Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study |
| Q101146650 | Building capacity for air pollution epidemiology in India |
| Q43539791 | Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation |
| Q85856456 | Cardioversion without oral anticoagulation--is it risk-taking? |
| Q98654692 | Changes in 24-h ambulatory blood pressure following restoration of sinus rhythm in patients with atrial fibrillation |
| Q85643983 | Chest compression alone cardiopulmonary resuscitation is associated with better long-term survival compared with standard cardiopulmonary resuscitation |
| Q90177654 | Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels |
| Q38419246 | Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial |
| Q39228463 | Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure. |
| Q45081193 | Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block |
| Q84984679 | Compression-Only CPR or Standard CPR in Out-of-Hospital Cardiac Arrest |
| Q47228856 | Computerised assistance for warfarin dosage--effects on treatment quality |
| Q82621754 | Congestive heart failure with and without atrial fibrillation - different patient populations? |
| Q51158976 | Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. |
| Q41080541 | Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording |
| Q57215242 | Defibrillator implantation early after myocardial infarction |
| Q38878668 | Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis |
| Q89107524 | Different defibrillation strategies in survivors after out-of-hospital cardiac arrest |
| Q47130709 | Dispatch of Firefighters and Police Officers in Out-of-Hospital Cardiac Arrest: A Nationwide Prospective Cohort Trial Using Propensity Score Analysis |
| Q81153329 | Dispatcher-assisted telephone-guided cardiopulmonary resuscitation: an underused lifesaving system |
| Q38943915 | Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry |
| Q45355004 | Dual dispatch early defibrillation in out-of-hospital cardiac arrest: the SALSA-pilot |
| Q41681039 | Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest |
| Q54559714 | Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients. |
| Q59313024 | Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation |
| Q53111119 | Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. |
| Q90695680 | Electrocardiography Screening for Atrial Fibrillation |
| Q51368043 | Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. |
| Q40388084 | Expanding the first link in the chain of survival - Experiences from dispatcher referral of callers to AED locations |
| Q47789270 | Favourable cost-benefit in an early defibrillation programme using dual dispatch of ambulance and fire services in out-of-hospital cardiac arrest |
| Q55101913 | Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study. |
| Q39507863 | Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study. |
| Q50131546 | High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm. |
| Q44549136 | High prevalence of atrial fibrillation among patients with ischemic stroke. |
| Q43613445 | Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. |
| Q50969423 | Improved screening for silent atrial fibrillation after ischaemic stroke. |
| Q43615777 | Improved survival after out-of-hospital cardiac arrest is associated with an increase in proportion of emergency crew--witnessed cases and bystander cardiopulmonary resuscitation |
| Q38805130 | Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter |
| Q51104394 | Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). |
| Q80725166 | Influence of left bundle branch block on long-term mortality in a population with heart failure |
| Q34524391 | Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias |
| Q40896985 | Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism? |
| Q57914449 | Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study |
| Q92072502 | Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation |
| Q50097026 | Less dementia with oral anticoagulation in atrial fibrillation. |
| Q50775158 | Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. |
| Q57790939 | Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion |
| Q38412546 | Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study |
| Q90127094 | MediYoga as a part of a self-management programme among patients with paroxysmal atrial fibrillation - a randomised study |
| Q90076595 | Medicine and the media: Medical experts' problems and solutions while working with journalists |
| Q46262088 | Meeting abstracts from the first European Emergency Medical Services congress (EMS2016): Copenhagen, Denmark. 30 May - 1 June 2016. |
| Q51524674 | Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure. |
| Q41681031 | Mobile-phone dispatch of laypersons for CPR in out-of-hospital cardiac arrest. |
| Q37331167 | Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms |
| Q79165576 | Monitoring compliance to guidelines |
| Q47304262 | Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation |
| Q45354464 | More defibrillators needed in society |
| Q48561895 | NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach |
| Q48422049 | NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion. |
| Q45343563 | Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study |
| Q37184130 | Out of hospital cardiac arrest outside home in Sweden, change in characteristics, outcome and availability for public access defibrillation |
| Q83567251 | Outcome after out-of-hospital cardiac arrest witnessed by EMS: changes over time and factors of importance for outcome in Sweden |
| Q83367315 | Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring |
| Q43674159 | Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). |
| Q82677669 | Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines |
| Q34432030 | RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers |
| Q51837550 | Rapid atrial pacing does not decrease the atrial defibrillation threshold. |
| Q83157851 | Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009 |
| Q39862290 | Rapid effects of air pollution on ventricular arrhythmias. |
| Q53253426 | Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation. |
| Q38907584 | Registry-based studies of atrial fibrillation from Sweden and Denmark, 2000-2014. |
| Q102077290 | Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study” |
| Q53096879 | Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". |
| Q47918027 | ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts |
| Q50745942 | Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. |
| Q92370801 | Screening for Atrial Fibrillation to Initiate Stroke-Protective Therapy |
| Q30234524 | Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration |
| Q31119285 | Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population |
| Q50094844 | Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofi |
| Q91438856 | Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration |
| Q50774310 | Self-limited bursts of atrial fibrillation following successful cardioversion. |
| Q83034771 | Short-term ECG for out of hospital detection of silent atrial fibrillation episodes |
| Q40155244 | Short-term effects of air pollution on out-of-hospital cardiac arrest in Stockholm |
| Q91601731 | Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study |
| Q48383979 | Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design. |
| Q85942427 | Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention |
| Q46142380 | Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation |
| Q53252730 | Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). |
| Q92723888 | Survival in Out-of-Hospital Cardiac Arrest After Standard Cardiopulmonary Resuscitation or Chest Compressions Only Before Arrival of Emergency Medical Services: Nationwide Study During Three Guideline Periods |
| Q44801114 | Survival is similar after standard treatment and chest compression only in out-of-hospital bystander cardiopulmonary resuscitation |
| Q34031043 | Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry |
| Q91608870 | Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion |
| Q43720779 | The implementation of a dual dispatch system in out-of-hospital cardiac arrest is associated with improved short and long term survival |
| Q57790659 | The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin |
| Q86029712 | Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke |
| Q33154344 | Time relation between a syncopal event and documentation of atrioventricular block in patients with bifascicular block: clinical implications |
| Q40928690 | Unexplained acute chest pain in young adults: disease patterns and medication use 25 years later |
| Q34892646 | Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation |
| Q90777461 | Validity of daily self-pulse palpation for atrial fibrillation screening in patients 65 years and older: A cross-sectional study |
| Q47324362 | Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. |
| Q73224617 | What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter |
| Q86087713 | [Anticoagulants to more people can prevent many cases of stroke] |
| Q52355124 | [Doctors Back and Biorck had kings as patients]. |
| Q86087722 | [Electricity or drugs can convert atrial fibrillation] |
| Q95614930 | [Identification of paroxysmal, transient arrhythmias: Intermittent registration more efficient than the 24-hour Holter monitoring] |
| Q73050706 | [Implantable defibrillators after myocardial infarction. Expensive palliation or therapeutic breakthrough?] |
| Q86087730 | [Intriguing disease in a new perspective] |
| Q30556378 | [Jussi Bjorling's heart rate was 200 beats per minute]. |
| Q79163292 | [Medical safety at our airports--time for an emergency team at the Arlanda airport] |
| Q79845407 | [Mobile intensive care teams--a great deal remains to be proved] |
| Q84041624 | [More people can be saved after out-of-hospital cardiac arrest. 10 000 affected every year--just about 300 survive] |
| Q86087709 | [Pharmaceutical regulation of rhythm and frequency--to relieve symptoms] |
| Q81512765 | [Quality assurance of cardiologic services. The National Board of Health and Welfare's guidelines, local inspections and national registries are good tools] |
| Q82878167 | [Soon more and more Swedish centenarians. Increased 10 times since 1970] |
| Q83764675 | [The registration of Swedish fibrillation surgery fails. What about the evidence?] |
| Q95619172 | [Uncertain if drugs do any good after cardiac arrest] |